Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Atreca, Inc. logo — company profile

Atreca, Inc.

Founded 2011 United States South San Francisco, United States 25 employees Post-IPO Equity Total: $347.86M Biotechnology, Health Care +1

General Information

Company Name Atreca, Inc.
Founded Year 2011
Location United States South San Francisco, United States
Founders / Decision Makers
Team member Team member
Employees 25
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Atreca, Inc.. To contact Atreca, Inc., visit atreca.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Atreca, Inc. compare?

A PDF of Atreca, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Atreca, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Atreca, Inc.

Atreca, Inc. is a biotechnology company focused on developing novel therapeutics with a deep understanding of the human immune response, particularly in the field of innovative cancer immunotherapeutics. Founded in 2010, Atreca leverages its Immune Repertoire Capture™ (IRC™) technology to gain unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. The company was created by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. Atreca recently received a significant $125.00MPost-IPO Equity investment on 15 July 2020. Located in the United States, Atreca is actively seeking talented individuals dedicated to making a positive impact on human health. The company's open positions can be found at: http://www.atreca.com/careers/.

Business keywords: Cancer Immunotherapy, Therapeutics, Immune Repertoire Capture, Clinical Outcomes, Immune Response, Cancer Research, Healthcare Innovation, Investment, Human Health, Scientific Innovation, Biopharmaceuticals, Biomedical Technology

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $125.00M -
15 Jul 2020
Series C $125.00M 9
Aisling Capital Boxer Capital Redmile Group
Aisling Capital, Boxer Capital +7
12 Sep 2018
Series B $35.00M 3
Wellington Management Mission BioCapital Cormorant Asset Management
Wellington Management, Mission BioCapital +1
17 Aug 2017
Series A $56.00M 4
Mission Bay Capital Bill & Melinda Gates Foundation Evolution VC Partners
Mission Bay Capital, Bill & Melinda Gates Foundation +2
04 Nov 2015
Debt Financing $700.00K -
29 Aug 2013
Venture Round $6.00M 2
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation, Ling Wong
25 Sep 2012
Debt Financing $160.00K -
18 Oct 2011

Atreca, Inc. Alternatives & Competitors

Atreca, Inc. vs
SQZ Biotechnologies
SQZ Biotechnologies United States

Unlocking the full potential of cell therapies for patients around the world

Grant
18 employees
Biotechnology, Health and Wellness
Atreca, Inc. vs
Immunaeon
Immunaeon United States

Connecting Today's Science to Tomorrow's Cures

5 employees
Biopharma, Biotechnology
Atreca, Inc. vs
Eikon Therapeutics
Eikon Therapeutics United States

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing break...

Series D
429 employees
Biotechnology, Health Care
Compare Atreca, Inc. vs Eikon Therapeutics

FAQ About Atreca, Inc.

Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients...
Atreca, Inc. was founded in 2011.
Atreca, Inc. is headquartered in South San Francisco, United States.
Atreca, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Cancer Immunotherapy, Therapeutics, Immune Repertoire Capture and Clinical Outcomes.
Atreca, Inc. has approximately 25 employees.
Atreca, Inc. has completed 7 funding rounds, raising a total of $347.86M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Atreca, Inc. include SQZ Biotechnologies, Immunaeon, Eikon Therapeutics, Georgiamune Inc., Intensity Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atreca, Inc. and SQZ Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Atreca, Inc., https://bouncewatch.com/company/atreca-inc, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes